InvestorsHub Logo
Post# of 173796
Next 10
Followers 39
Posts 2424
Boards Moderated 0
Alias Born 01/14/2015

Re: None

Monday, 01/23/2017 7:55:30 PM

Monday, January 23, 2017 7:55:30 PM

Post# of 173796
I know this was talked about but I think it's worth reiterating. The new CEO did not acquire the new shares recently by way of compensation or bonus like most OTC CEO's do. Korenko paid for the new shares on the open market at a .15 price tag which is the range this is trading now. 700k shares at .15 he shelled out $105,000!

Again - most CEO's in pinkie land acquire and build their positions from vested shares via compensation or bonus. This makes quite the statement that the new CEO is putting his own money on the baseline.

Also for the newbies. Cadwell, who is now the Chairman converted over $5 million of the his loan to ADMD for common shares equaling $1.50 per share. The only way for him to make his money back is to get the share price to this range.

Aside from the great moves of hiring Korenko as new CEO and placement of Cadwell into the Chairman seat as well as obvious cancer cure (Radiogel) progress that will finally be realized, from a pure fundamentals reason of the statements above is why I'm re-loading here very very heavy!

GLTA

GO $ADMD


Source: http://dailyquint.com/2017-01-23-michael-k-korenko-purchases-700000-shares-of-advanced-medical-isotope-corporation-admd-stock/

http://ih.advfn.com/p.php?pid=nmona&article=73642477

Source: https://www.isotopeworld.com/2015/10/07/advanced-medical-isotope-corporation-completes-substantial-capital-restructuring-activities-and-continues-product-development/ (this states .015 conversion but is prior to the 100:1 reverse split so new calculation is now $1.50)



I don't believe in pessimism. If something doesn't come up the way you want, forge ahead. If you think it's going to rain, it will.
Clint Eastwood

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News